Study Furthers Understanding Of Critical Alzheimer's Disease Gene

April 07, 1999

Researchers have cracked part of the code for an important gene function in familial Alzheimer's disease (FAD), an early-onset type of AD. Alzheimer's disease is the most common cause of dementia. Working with cells in culture that had been altered to overexpress the amyloid precursor protein (APP), the researchers were able to document that expression of a mutant form of the presenilin-1 (PS-1) protein caused a significant reduction in the amount of amyloid formed. This continuing study of the mechanisms of plaque formation, researchers believe, moves them ever closer to the possible development of novel drugs to intervene in the processes leading up to Alzheimer's dementia.

Naturally occurring mutations in PS-1 are found in about 40 percent of people with FAD. Previous studies have suggested that these inherited PS-1 gene mutations increase the amount of amyloid clipped out from the larger amyloid precursor protein, but no one could determine how that clipping occurred. Researchers named the elusive and not-well-understood enzyme that is involved in the clipping, gamma secretase. The current research suggests that either PS-1 may be the long sought gamma-secretase, or that PS-1 is essential for gamma secretase's ability to clip amyloid.

The study of mutated PS-1 protein was published in the April 8, 1999 issue of Nature by Dr. Dennis J. Selkoe and his colleagues at Harvard Medical School and Brigham and Women's Hospital, Boston, and the University of Tennessee, Memphis. Their work focuses on the chemical events that may lead to the development of brain damage and the symptoms of dementia. The National Institute on Aging (NIA), and the National Institute of Neurological Disorders and Stroke (NINDS), two components of the National Institutes of Health (NIH), funded the study. In their search to explain why the amyloid fragments clump into plaques, which surround the brain cells of Alzheimer's disease patients, Dr. Selkoe's group gained an insight into the interaction of two key molecules involved in amyloid formation. When they altered the sequence of amino acids of the presenilin protein from the normal sequence in two critical locations, buried within the cell membrane, amyloid formation was reduced.

According to Dr. D. Stephen Snyder, who directs studies of the Etiology of Alzheimer's Disease at NIA's Neuroscience and Neuropsychology of Aging Program, "These studies have implications for the treatment of AD and related disorders of amyloid accumulation. If this gamma-secretase finding proves true, it could lead to significant advances in therapeutics research by showing us how to intervene before plaques form."
-end-
The NIA is the lead federal agency supporting and conducting Alzheimer's disease research, including studies of the basic, clinical, and epidemiological aspects of this and other related dementias of aging. The NIA's Alzheimer's Disease Education and Referral (ADEAR) Center can provide more information on Alzheimer's disease by calling 1-800-438-4380.

The NINDS is the nation's premier supporter of research on the brain and nervous system and a lead agency for the Congressionally designated Decade of the Brain. NINDS celebrates 50 years of brain and nervous system research in the year 2000.

Michael S. Wolfe, Weiming Xia, Beth L. Ostaszewski, Thekla S. Diehl, W. Taylor Kimberly, and Dennis J. Selkoe. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature, 398, (513-517).



NIH/National Institute on Aging

Related Aging Articles from Brightsurf:

Surprises in 'active' aging
Aging is a process that affects not only living beings.

Aging-US: 'From Causes of Aging to Death from COVID-19' by Mikhail V. Blagosklonny
Aging-US recently published ''From Causes of Aging to Death from COVID-19'' by Blagosklonny et al. which reported that COVID-19 is not deadly early in life, but mortality increases exponentially with age - which is the strongest predictor of mortality.

Understanding the effect of aging on the genome
EPFL scientists have measured the molecular footprint that aging leaves on various mouse and human tissues.

Muscle aging: Stronger for longer
With life expectancy increasing, age-related diseases are also on the rise, including sarcopenia, the loss of muscle mass due to aging.

Aging memories may not be 'worse, 'just 'different'
A study from the Department of Psychological & Brain Sciences in Arts & Sciences adds nuance to the idea that an aging memory is a poor one and finds a potential correlation between the way people process the boundaries of events and episodic memory.

A new biomarker for the aging brain
Researchers at the RIKEN Center for Biosystems Dynamics Research (BDR) in Japan have identified changes in the aging brain related to blood circulation.

Scientists invented an aging vaccine
A new way to prevent autoimmune diseases associated with aging like atherosclerosis, Alzheimer's disease, and Parkinson's disease was described in the article.

The first roadmap for ovarian aging
Infertility likely stems from age-related decline of the ovaries, but the molecular mechanisms that lead to this decline have been unclear.

Researchers discover new cause of cell aging
New research from the USC Viterbi School of Engineering could be key to our understanding of how the aging process works.

Deep Aging Clocks: The emergence of AI-based biomarkers of aging and longevity
The advent of deep biomarkers of aging, longevity and mortality presents a range of non-obvious applications.

Read More: Aging News and Aging Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.